Depression is one of the most widespread health conditions in the world. According to the World Health Organization, it affects more than 280 million people globally, cutting across age, gender, and ...

A new review of depression treatments suggests that the scientific evidence for many common strategies used when a first ...

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression - making it the first FDA-approved oral pill in the United States specifically for ...

A new study on the efficacy of a drug, Zuranolone, to treat postpartum depression, shows promising results. As the country grapples with a maternal healthcare crisis and insufficient infrastructure ...